• SU6656 Src Tyrosine Kinases Inhibitor: Reliable Protocols &

  2026-06-03

  This article addresses real-world challenges in cell-based assays and megakaryocyte differentiation, illustrating how SU6656 Src tyrosine kinases inhibitor (SKU B5839) delivers reproducible, data-backed solutions. Bench researchers will find scenario-driven Q&A, practical protocol tips, and evidence-based advice for optimizing workflows.

• Brefeldin A: Optimizing ER Stress and Apoptosis Assays in Ca

  2026-06-03

  Brefeldin A (BFA) is a gold-standard ER stress inducer and vesicular transport inhibitor, essential for dissecting protein trafficking, apoptosis, and endothelial dysfunction in translational cancer and vascular biology. This guide covers advanced workflows, troubleshooting, and practical insights, drawing on recent biomarker discoveries and mechanistic research to elevate your experimental success with APExBIO’s Brefeldin A.

• IgSF6 Deficiency Enhances ER Stress and Antibacterial Activi

  2026-06-02

  This study uncovers how deficiency of the ER-localized immunoglobulin IgSF6 in intestinal macrophages amplifies antibacterial activity through increased ER stress and inflammatory signaling. The findings provide mechanistic insight into the regulation of gut immune homeostasis and highlight new avenues for studying macrophage-driven defense and inflammation.

• Biotin-XX Tyramide Reagent: Membrane-Impermeant Signal Ampli

  2026-06-02

  Biotin-XX Tyramide Reagent enables high-sensitivity, membrane-impermeant cell surface protein labeling through tyramide signal amplification. Its long polar linker restricts biotinylation to extracellular targets, improving specificity for immunohistochemistry and in situ hybridization. This reagent, supplied by APExBIO, is benchmarked in neuroscience applications and offers robust, selective profiling for low-abundance proteins.

• Spatially Concentrated ABEs Correct PLP1 Mutations in Oligod

  2026-06-01

  This study introduces a spatially concentrated adenine base editor (cABE) strategy to efficiently correct pathogenic PLP1 mutations in oligodendrocytes, addressing a major challenge in gene therapy for myelin disorders. The approach enhances nuclear localization of the editing machinery, improving on-target efficiency while minimizing transcriptome-wide off-target effects.

• 10 mM dNTP Mixture: Optimizing DNA Synthesis and LNP Workflo

  2026-06-01

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture empowers researchers to achieve high-fidelity PCR, consistent DNA sequencing, and robust LNP-based nucleic acid delivery. Its equimolar, pH-stabilized formulation eliminates common workflow bottlenecks and ensures reproducibility across a spectrum of molecular biology applications.

• Enhancing Luteolin Oral Bioavailability via P-gp Inhibition

  2026-05-31

  This study introduces a novel self-microemulsifying drug delivery system (Luteolin-SME) that dramatically boosts luteolin's oral bioavailability by inhibiting P-glycoprotein-mediated efflux. The findings provide a robust pharmacokinetic and mechanistic foundation for overcoming absorption barriers in bioactive natural compounds.

• Structural Basis of TRPM3 Modulation by Neurosteroids and Pr

  2026-05-30

  Yin et al. present cryo-EM structures revealing how neurosteroids and the anticonvulsant primidone interact with the TRPM3 ion channel, a molecular target implicated in pain and neurodevelopmental disorders. Their work identifies ligand binding sites, illuminates mechanisms of channel gating, and provides a foundation for drug development targeting TRPM3.

• BMS 309403: Optimizing FABP4 Inhibitor Workflows in Atherosc

  2026-05-29

  BMS 309403 stands out as a potent, selective FABP4 inhibitor, empowering researchers to precisely dissect the lipid metabolism-inflammation axis in metabolic disease models. This guide delivers actionable protocols, experimental troubleshooting, and evidence-driven insights for maximizing impact in atherosclerosis and type 2 diabetes research.

• IL-1β Tetrapeptide Motif Controls Inflammatory Caspase Activ

  2026-05-29

  This study reveals that the P4–P1 tetrapeptide motif adjacent to the caspase cleavage site in IL-1β critically determines its recruitment and activation by inflammatory caspases. These findings advance the mechanistic understanding of cytokine maturation and have direct implications for inflammation and pyroptosis research.

• Protein A/G Magnetic Beads: Practical Guide for Immunoprecip

  2026-05-28

  Protein A/G Magnetic Beads (SKU K1305) enable efficient isolation and purification of IgG antibodies from complex biological samples, supporting immunoprecipitation, co-IP, and Ch-IP workflows. These recombinant Protein A and Protein G beads minimize non-specific binding and streamline protein-protein interaction analysis. They are not appropriate for diagnostic or medical applications and should not be used outside the recommended storage and handling parameters.

• BKT140 (BL-8040): Mechanisms & Strategy for CXCR4-Targeted O

  2026-05-28

  Explore how BKT140 (BL-8040), a potent CXCR4 antagonist, bridges molecular insights and translational strategy in oncology research. This article synthesizes current theranostic advances, mechanistic rationale, and practical protocol guidance, offering strategic perspectives for translational scientists seeking to harness CXCR4 inhibition for tumor control and hematopoietic stem cell mobilization.

• Nanoparticle-Mediated PTEN mRNA Delivery to Overcome Trastuz

  2026-05-27

  This article examines a recent study that developed tumor microenvironment-responsive nanoparticles for systemic delivery of PTEN mRNA to reverse trastuzumab resistance in HER2-positive breast cancer. The research demonstrates how restoring PTEN expression and inhibiting the PI3K/Akt pathway can effectively suppress tumor growth and overcome acquired therapy resistance.

• Deracoxib: Advanced COX-2 Inhibition Strategies in Canine On

  2026-05-27

  Explore how Deracoxib, a selective COX-2 inhibitor, transforms inflammation and cancer biology research through precise molecular targeting and optimized assay design. This article delivers nuanced insights and practical protocols that go beyond standard guidance.

• Fluo-4 AM: Advanced Fluorescent Calcium Indicator Workflows

  2026-05-26

  Fluo-4 AM is a high-performance fluorescent calcium indicator that streamlines real-time intracellular calcium measurement in both basic and translational research. This guide details practical workflows, protocol enhancements, and troubleshooting strategies—bridging cutting-edge bioelectronics and cell signaling science.

16720 records 1/1115 page Next 12345 下5页 Last page